Filter
493
Filtered Results: 493
Text search:
Gnorrhoea
Featured
Recommendations
51
New Publications
138
Language
Document type
No document type
276
Guidelines
90
Studies & Reports
66
Manuals
17
Strategic & Response Plan
17
Fact sheets
10
Situation Updates
5
Training Material
4
Brochures
3
Infographics
3
Resource Platforms
1
Videos
1
Countries / Regions
Nepal
19
South Africa
19
India
18
Nigeria
14
Africa
14
Tanzania
14
Kenya
10
Global
10
Philippines
9
Malawi
7
Latin America and the Carribbean
7
Ukraine
6
Rwanda
6
Namibia
6
Ghana
5
Zimbabwe
5
Asia
5
Germany
5
Uganda
5
Lesotho
4
Sierra Leone
4
Cameroon
4
Bangladesh
4
Zambia
4
Indonesia
4
Myanmar / Burma
4
Senegal
3
Eswatini/ Swaziland
3
Switzerland
2
Colombia
2
China
2
Peru
2
Mozambique
2
West and Central Africa
2
Western and Central Europe
2
East and Southern Africa
2
Argentina
2
Eastern Europe
2
Central African Republic
2
Ethiopia
2
South Sudan
2
Liberia
2
Pakistan
2
Thailand
1
Serbia
1
Syria
1
Iran
1
Albania
1
Laos
1
Burkina Faso
1
USA
1
Cambodia
1
Guinea-Bissau
1
Jordan
1
Congo, Democratic Republic of
1
Western Pacific Region
1
Paraguay
1
Uruguay
1
Turkmenistan
1
Mauritius
1
Southern Africa
1
Vietnam
1
Brazil
1
Russia
1
Egypt
1
Yemen
1
Georgia
1
Angola
1
Botswana
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
170
Clinical Guidelines
42
Women & Child Health
36
Public Health
14
Capacity Building
13
Key Resources
11
Pharmacy & Technologies
9
Toolboxes
AMR
110
HIV
99
Pharmacy
24
Refugee
21
TB
11
Conflict
8
Rapid Response
7
Caregiver
7
Planetary Health
6
NTDs
5
Global Health Education
4
Ebola & Marburg
3
Mental Health
2
Disability
2
Natural Hazards
1
COVID-19
1
NCDs
1
Zika
1
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 11, November 2017
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
Kit sanitaire d’urgence interinstitutions
recommended
Médicaments et dispositifs médicaux pour une population de
10 000 personnes pendant environ 3 mois
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
Severe bacterial infections are a leading cause of morbidity and mortality among people with advanced HIV disease, after tuberculosis and cryptococcal disease. For countries to reach the end-AIDS targets for 2030, there is a need to establish a roadmap for managing severe bacterial infections and re...
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire population of Uganda, as a means of providing satisfactory health care and safeguarding the appropriate us...
Scientific advice
Prevention and control of communicable diseases in prison settings.
Global HIV Strategic Information Working Group
Accessed: 29.02.2020
In emergency or humanitarian settings, mobile clinics are used to bring essential lifesaving health care to communities affected by crises. Though there are standard emergency benefit packages for health services during emergencies, there are however no agreed or standard way of running mobile clini...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
